Clinical Trial Update: Treatment With AX200 for Acute Ischemic Stroke [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating AX200 for acute ischemic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• AX200

Snippet

Sponsor: Axaron Bioscience AG | Conditions: Cerebral Stroke | Phase 2 | Status: COMPLETED